164 related articles for article (PubMed ID: 34587898)
1. The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC.
Shen K; Wei Y; Lv T; Song Y; Jiang X; Lu Z; Zhan P; Wang X; Fan M; Lu W
BMC Bioinformatics; 2021 Sep; 22(1):471. PubMed ID: 34587898
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
4.
Chen B; Lai J; Dai D; Chen R; Li X; Liao N
Aging (Albany NY); 2019 Dec; 11(23):11124-11135. PubMed ID: 31790361
[TBL] [Abstract][Full Text] [Related]
5. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.
Sun Y; Han Y; Wang X; Wang W; Wang X; Wen M; Xia J; Xing H; Li X; Zhang Z
Oncol Rep; 2016 Aug; 36(2):1030-40. PubMed ID: 27350337
[TBL] [Abstract][Full Text] [Related]
6. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
7. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
8. BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma.
Wang XF; Lei W; Liu CM; Yang J; Zhu YH
Int Immunopharmacol; 2022 Jun; 107():108652. PubMed ID: 35286914
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
Liu X; Xu Q; Li Z; Xiong B
Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
[TBL] [Abstract][Full Text] [Related]
13. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J
Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566
[No Abstract] [Full Text] [Related]
14. Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.
Ju FJ; Meng FQ; Hu HL; Liu J
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5787-5794. PubMed ID: 31298330
[TBL] [Abstract][Full Text] [Related]
15. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Fang L; Yu W; Yu G; Zhong F; Ye B
Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
[TBL] [Abstract][Full Text] [Related]
16. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
17.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
18. ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.
Yang Z; Tian H; Bie F; Xu J; Zhou Z; Yang J; Li R; Peng Y; Bai G; Tian Y; Chen Y; Liu L; Fan T; Xiao C; Zheng Y; Zheng B; Wang J; Li C; Gao S; He J
Front Immunol; 2021; 12():788985. PubMed ID: 34992605
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
[TBL] [Abstract][Full Text] [Related]
20. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]